The world needs a pandemic preparedness and response strategy built on equitable and representative decision-making.
At their meeting in Bali in mid-July, G20 finance ministers reaffirmed their commitment to co-ordinated action to get the Covid-19 pandemic under control and better prepare for the next global health emergency. A central topic was the creation of a new financial intermediary fund (FIF) to address pandemic preparedness and response (PPR), under the trusteeship of the World Bank and with the World Health Organization playing a central technical and co-ordinating role. The goal is to close some of the annual PPR financing gap of $10.5 billion and help strengthen capacities that are critical to protecting global health, including genomic sequencing and drug manufacturing.
Over the next month, the G20, the World Bank and the WHO will finalise the FIF design, under heavy external pressure to develop an equitable and inclusive governance structure. The Indonesian G20 presidency has enabled some preliminary agreements that move in the right direction. For example, there is an emerging consensus that the FIF’s governance must include low- and middle-income countries, non-G20 partners and civil society. Moreover, G20 countries acknowledge that the FIF must build on the existing global health framework for PPR, with a central role for the WHO. This is a positive departure from the World Bank’s May 2022 White Paper, which proposed a deeply-retrograde, insular design whereby (mainly rich country) donors would make all the decisions and consult others (or not) as they chose.
Universal representation
The next step is for the G20 to recognise more explicitly that an effective PPR mechanism, as a global common good, requires an FIF model based on universal contributions (according to capacity) and representation, and universal access to benefits. The world desperately needs an FIF governance structure that can help fill critical gaps quickly and effectively. This requires a decision-making body that is agile, but also widely viewed as legitimate and therefore able to make hard decisions without months of consensus-building diplomacy.
But while all current FIF stakeholders seem to agree on inclusive governance in principle, design discussions are still happening with only the founding donors in the room. Lower-income countries and civil-society representatives remain outside. The G20 should set a deadline: by the beginning of next month, all stakeholders should be fully included in design conversations via a constituency-based model that gives equal weight to all voices, irrespective of their financial contributions. This includes a voting role for civil society—an increasingly important norm in global health governance.
The FIF should mark a long-overdue departure from the current approach, which treats PPR as a favour rich countries do for poorer countries. Nothing could be further from the truth. Recall that it was South Africa’s novel approach to low-cost, high-impact genomic sequencing which helped the world detect and understand the new Omicron variant last November—a tremendous global public service. But about one-third of all countries currently do not have the resources and capacity to do any genomic sequencing, with huge gaps across Africa and Latin America in particular.
These are also regions where vaccine hoarding by the global north has meant that Covid-19 continues to circulate among largely unvaccinated populations and mutates at rates which have left public health officials and pharmaceutical companies struggling to keep up. The FIF will work only if all countries—starting with the G20—are bought in, and all countries do their share to detect, contain and confront outbreaks with the full kit of diagnostic, treatment and prevention tools.
Central piece
The inclusion of the WHO in the FIF is a central piece of the governance structure. Hardwiring it into the FIF’s design should include having the WHO chair the technical advisory group which will assess and weigh the evidence and data required to inform priorities. The WHO is not only the leading hub of scientific expertise and co-ordination for global health: it also represents 194 countries, providing essential legitimacy.
While the FIF is meant to augment existing donor and national PPR investment in public health, there are already signs that its fundraising could cannibalise the resources of well-tested, complementary mechanisms, such as the Global Fund and the Coalition for Epidemic Preparedness Innovations. If the FIF ends up undermining resourcing for the rest of the global PPR framework, simply to become the shiny new deliverable at this year’s G20 summit, it will have done more harm than good for global health security.
The scale of financial need—particularly in low- and middle-income countries confronting a massive debt crisis and soaring inflation—far surpasses what even the most effective FIF will be able to deliver. As part of its commitments to PPR, the G20 should redouble its efforts to bring China and private creditors to the table to renegotiate mounting debt burdens through its Common Framework, or face the risk of many more Sri Lanka-style debt defaults and growing social and political unrest in the coming months and years.
Debt relief
To ensure the success of the FIF and global PPR efforts more broadly, the G20 must take all measures within its control to provide debt relief and free up fiscal space in low- and middle-income countries. This includes extending the Common Framework and the Debt Service Suspension Initiative, and developing effective ways to ensure private-sector participation; eliminating austerity conditions from International Monetary Fund loans, which encourage countries to cut public spending in areas such as health; increasing liquidity through additional allocations of special drawing rights (the IMF’s reserve asset), and exploring more creative financing mechanisms such as the ‘debt for health’ swaps used by the Global Fund.
The new FIF proposal and broader G20 and World Bank actions on PPR cannot afford to deliver ‘health for some’—the wealthiest and most privileged. This is a morally bankrupt and woefully ineffective approach. Now is the time to pivot toward a more promising ‘health for all’ approach, starting with an inclusively-governed FIF and economic interventions which better enable low- and middle-income countries to invest as required in their own health systems.
Republication forbidden—copyright Project Syndicate 2022, ‘An effective pandemic response must be truly global’
Mariana Mazzucato is professor in the economics of innovation and public value at University College London, founding director of the UCL Institute for Innovation and Public Purpose and a co-chair of the Global Commission on the Economics of Water.
Jayati Ghosh, professor of economics at the University of Massachusetts Amherst, is a member of the Club of Rome’s Transformational Economics Commission and co-chair of the Independent Commission for the Reform of International Corporate Taxation.